Recently, a novel G protein-coupled receptor, GPR56, which inhibits VEGF production from the melanoma cell lines [40], as well as heparanase, which induces VEGF, were reported as possible tumor targets for influencing VGEF expression [41]. The gene discussed is ADGRG1; the disease is melanoma.